AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04814927 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etonogestrel implant
Description: Participants randomized to ETG implant will receive the implant at Visit 2.
Study NCT04814927 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levonorgestrel IUS
Description: Participants randomized to LNG intrauterine system will receive the IUS at Visit 2.
Study NCT04814927 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DMPA Sub-cutaneous
Description: Participants randomized to DMPA SC will receive the injection at Visit 2.
Study NCT04680585 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Enhanced Usual Care
Description: A standardized handout with information on what treatment options might be useful to start with based on EPDS score and stage of pregnancy or postpartum.
Study NCT04680585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enhanced Usual Care
Description: A standardized handout with information on what treatment options might be useful to start with based on EPDS score and stage of pregnancy or postpartum.
Study NCT04680585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MOVIN Care Platform
Description: Virtual collaborative care intervention with a stepped care approach in which a care coordinator directs participants to one or more evidence-based virtual interventions as appropriate.
Study NCT06169670 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Viality
Description: Viality is a lipoaspirate wash system designed to be used in the operating room in conjunction with, and attached to, a user-provided liposuction cannula, a vacuum source, and a waste canister.~Viality is to be used to filter and wash aspirated, harvested autologous adipose tissue for aesthetic body contouring. The system should be used with a legally marketed vacuum or aspirator apparatus as a source of suction. If harvested fat is to be re-implanted, the harvested fat is to be used without any additional manipulation. Viality is not intended to process autologous adipose tissue other than for aesthetic body contouring uses.
Study NCT06558864 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Subiculum RF-TC
Description: SEEG implantation after evaluation, record the interictal and ictal EEG, and perform Subiculum RF-TC.
Study NCT06330142 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Participation in 10 horse-assisted therapy sessions
Description: supporting children and teenagers undergoing radiotherapy with a horse-assisted therapy approach
Study NCT06486298 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vacuum Drain and Passive Drain insertion at abdominoplasty surgery
Description: Compare the subcutaneous collection with Vacuum Drain and Passive Drain insertion at abdominoplasty surgery
Study NCT06486298 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vacuum Drain and Passive Drain insertion at abdominoplasty surgery
Description: Compare the subcutaneous collection with Vacuum Drain and Passive Drain insertion at abdominoplasty surgery
Study NCT05222477 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: pelvic floor exercise
Description: pelvic floor exercises(intervention) will be applied for patients with nocturia and type 2 DM for 6 weeks, 3 times/week
Study NCT06201143 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BREATHING EXERCISE AND MOBILIZATION TRAINING
Description: After cesarean mobilization and breathing exercise training, the number of breathing exercises performed and the duration of mobilization will be recorded. Thus, the effectiveness of the training will be examined in detail.
Study NCT06201143 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: KINESIOLOGICAL TAPING + BREATHING EXERCISE AND MOBILIZATION TRAINING
Description: It will be the first study to use kinesiotaping, breathing exercise and mobilization training together.
Study NCT05077761 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active High-intensity laser therapy
Description: High-intensity laser therapy will be used in the contact method, with the laser beam irradiated over the hamstring muscle. Dosage and parameters for the laser will be calculated.~Parameters-~1. Wavelength- 980 nm~2. Intensity/Power density- 3W/cm2~3. Emission mode- Continuous Emission~4. Energy (Joules)- 490 J~5. Irradiation time- 70 Sec on each point~6. Peak power- 15 Watt~7. Irradiation points- 09
Study NCT05077761 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham High-intensity laser therapy
Description: Sham High-intensity laser therapy will be used in the contact method, without the laser beam irradiation over the hamstring muscle.
Study NCT05085210 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial random noise stimulation (tRNS)
Description: noninvasive current stimulation for 20 - 30 minutes stimulation on visual cortex (electrodes on surface of scalp, positioned O1 / O2 on EEG cap). 1mA max amplitude noise stimulation, frequencies from 100 Hz - 640 Hz.
Study NCT05085210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Computer Based Visual Training
Description: Dynamic visual stimuli are presented on specific locations of the visual field. Participant holds fixation on center of screen during presentation of visual stimuli. Participants will be presented with multiple trials of a motion discrimination task. Training will be performed for 2 weeks (10 consecutive weekdays), 30 minutes each day.
Study NCT05085210 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham stimulation
Description: 20-30 minutes sham stimulation on visual cortex. Participants receive identical setup to real stimulation. The device provides a short ramp on period to simulate the feeling of real stimulation at the start but no current is delivered otherwise.
Study NCT05085210 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham stimulation
Description: 20-30 minutes sham stimulation on visual cortex. Participants receive identical setup to real stimulation. The device provides a short ramp on period to simulate the feeling of real stimulation at the start but no current is delivered otherwise.
Study NCT05085210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Based Visual Training
Description: • Dynamic visual stimuli are presented on specific locations of the visual field. Participant holds fixation on center point within the VR headset during presentation of visual stimuli. Participants will be presented with multiple trials of a motion discrimination task. Training will be performed for 2 weeks (10 consecutive weekdays), 30 minutes each day.
Study NCT06172543 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Creatine Monohydrate
Description: Participants were assigned to ingest a single serving daily of either A) a 25-gram dose of whey protein isolate + 25-gram dose of carbohydrate powder (ProCarb); or B) a 25-gram dose of Whey Protein Isolate + 25-gram dose of carbohydrate powder + 5-gram dose of creatine monohydrate (Creatine) for a 17-21-day period.
Study NCT06172543 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: A 25-gram dose of whey protein isolate + 25-gram dose of carbohydrate powder (ProCarb)
Study NCT05222477 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Abdominal muscles exercise
Description: abdominal exercises (intervention) will be applied for patients with nocturia and type 2 DM for 6 weeks, 3 times/week
Study NCT04899089 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: The computerized training exercises and brain games help stimulate cognitive functions while providing real-time monitoring on the evolution of participants' skills.
Study NCT04899089 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Trivia Training
Description: The computerized trivia training asks participants to answer general questions related to pop culture, science, geography, etc. Participants can use online sources to search for answers and will be provided feedback on their accuracy.
Study NCT05931315 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: CaroRite™
Description: One capsule to be taken immediately post-dinner / with dinner
Study NCT05931315 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One capsule to be taken immediately post-dinner / with dinner
Study NCT06189950 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intracranial stent for wide-necked aneurysms
Description: Intracranial stent for wide-necked aneurysms
Study NCT06189950 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intracranial stent for wide-necked aneurysms
Description: Intracranial stent for wide-necked aneurysms
Study NCT05049720 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Defibrillation using the Extravascular ICD
Description: VT/VF induction attempted for defibrillation testing, as well as requisite electrical testing.
Study NCT05608655 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DKutting LL balloon
Description: After pre-dilation balloon is used (if any), DKutting LL balloon is used as final dilatation balloon before Stent implantation or Drug Coated Balloon deployment
Study NCT05608655 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Chocolate balloon
Description: After pre-dilation balloon is used (if any), Chocolate balloon is used as final dilatation balloon before Stent implantation or Drug Coated Balloon deployment
Study NCT06097780 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: NestaCell®
Description: Human Dental Pulp Stem Cells (hDPSCs).
Study NCT06097780 — intervention group
Intervention type: GENETIC
Group type: PLACEBO_COMPARATOR
Intervention: NestaCell®
Description: Human Dental Pulp Stem Cells (hDPSCs).
Study NCT05391971 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: At the C6 level, a total of 7cc of 0.5% bupivacaine will be injected slowly at this level, with negative aspiration every 2cc. The same procedure will be repeated at the C4 level directed towards the upper cervical ganglion ventral to the longus colli muscle with a total of 3cc of 0.5% bupivacaine.
Study NCT05391971 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: At the C6 level, a total of 7cc of saline control will be injected slowly at this level, with negative aspiration every 2cc. The same procedure will be repeated at the C4 level directed towards the upper cervical ganglion ventral to the longus colli muscle with a total of 3cc of saline control.
Study NCT05609526 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Compression Therapy
Description: 6, 8, 10 and 12 cm short tension bandages multi-layered and will be applied specifically to the extremity. Starting with the finger bandage, the pressure will be reduced as it goes distally.
Study NCT05609526 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Description: Maximum inspiratory intraoral pressure (MIP) and expiratory intraoral pressure (MEP) will be measured before patients begin IMT. Total training time per day will be 30 minutes.
Study NCT05788198 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrated care
Description: The intervention will be modelled based on the most frequently reported patient, family physician and specialist barriers in depression management. In this project, multiple interventions aiming to tackle these barriers will be set up, with the WHO Framework on Integrated People-Centred Health Services (IPCHS) serving as conceptual backbone to the study (Table 1). The IPCHS distinguishes five interdependent strategies supporting a shift in healthcare delivery, management and funding towards universal health coverage. These strategies are:~1. empowering and engaging people and communities;~2. strengthening governance and accountability;~3. reorienting the model of care;~4. coordinating services within and across sectors;~5. creating an enabling environment.
Study NCT06520059 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Platelet rich-plasma - PRP - intraosseous and intra-articular admnistration
Description: Group 1 will receive two intraosseous injections of PRP and a subsequent/synchronous intra-articular injection of PRP on the same day.~Group 2 will only receive two intra-articular injections of PRP, separated by one week.
Study NCT05609526 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Calf muscle exercise training
Description: A strengthening treatment program will be applied to the calf muscles.dorsiflexors and plantar flexors will consist of static stretching exercise, isotonic resistance exercise with elastic resistance bands, heel and toe raising in both feet, followed by toe raising and lowering without raising the heel.
Study NCT04698187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CMP-001
Description: Subjects will receive CMP-001 10 mg IT weekly for 7 doses after which CMP-001 will be administered every 3 weeks (Q3W).
Study NCT04698187 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Nivolumab 360 mg IV is administered Q3W.
Study NCT02590393 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: E-cigarettes
Description: Participants will be asked to switch from cigarette use to use of e-cigarettes for eight weeks.
Study NCT05530629 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: resistance training
Description: resistance training lasts for 12 weeks, three times a week, one hour each time, and the program of resistance training in the experimental group was divided into 10 exercises: Chest press, Lat pull down, Shoulder press, Squat, Leg extension, Leg curl, Bicep curl, Triceps extension, abdominal crunches, lower back exercises.
Study NCT05530629 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Normal P.E. course
Description: Carry out general teaching content according to the college syllabus lasts for 12 weeks , three times a week, one hour each time, and the program of Normal P.E. course in the control group will be Physical recovery exercises, learn and practice queue formation, calisthenics, five step fists, long fist and Basic movements of Gymnastics gradually changed by week.
Study NCT04944862 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CDX-0159
Description: administered intravenously
Study NCT04944862 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: administered intravenously
Study NCT06454266 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ORM regimen
Description: The subjects received ORM regimen treatment every 21 days for a total of 6 cycles. The specific medication is as follows  Obutinib tablets 150mg qd d1-21 (suspended 2 days before MTX use until MTX drops to safe concentration) Rituximab 375mg/m2, d1 Methotrexate 3g/m2, d2
Study NCT05444127 — intervention group
Intervention type: OTHER
Intervention: Saliva samples
Description: A saliva sample is added by research for all patients, as well as an oral quality of life questionnaire. For the witnesses, participation also entails the completion of the standardized oral examination (potentially longer than the assessment that would have been carried out as part of the treatment) and the administration of the oral quality of life questionnaire.
Study NCT05655806 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aminophylline bolus then infusion
Description: half an hour before discontinuation of isoflurane
Study NCT05655806 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: aminophylline bolus
Description: after discontinuation of isoflurane
Study NCT05655806 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: given as placebo
Study NCT06657300 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRP
Description: A single dose of 1 ml PRP (Vacusera) was injected into the 1st CMC joint of the first group. Injection was performed under USG (Clarius; L7 HD Linear Ultrasound Scanner) guidance by the same physician after skin sterilization.
Study NCT06657300 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroid
Description: A single dose of 20 mg(1ml) of methyl-prednisolone (Depo-Medrol) (complemented to 1 ml by adding 0.5 ml of saline) was injected to the 1st CMC joint of the second group. Injection was performed under USG (Clarius; L7 HD Linear Ultrasound Scanner) guidance by the same physician after skin sterilization.
Study NCT06656585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individual food selectivity protocol
Description: Children in the experimental group wear Oculus headsets and interact with virtual foods for 20 minutes. In the Pairing in the Kitchen phase, Oculus is removed. Two identical plates with 6 foods are placed in front of the child. The operator, seated next to the child, interacts with the food without eating it, maintaining a positive expression, and discussing non-food topics. No prompts to eat are given, and the child can leave at any time. Progress to the next phase if the child sits calmly for 30 seconds across 3 sessions.~Shaping Phase: Two identical plates are prepared. The operator comments on the food and keeps a small container of the child's favorite food visible but out of reach. Any food-related behavior is reinforced with praise and the favorite food. Target behaviors are adjusted if no response occurs for 15 seconds or if negative emotions are observed. Differential reinforcement is used.
Study NCT06656585 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional food selectivity protocol
Description: Step 1:Pairing in the Kitchen Propose enjoyable activities in the kitchen. Move to Step 2 when the child plays in the kitchen for 5 minutes over 3 consecutive sessions.~Step 2:Transition to Kitchen Two plates with 6 identical foods are placed in the kitchen. The operator engages the child in a welcome game, waiting 30 seconds for spontaneous interaction. If no response, the operator prompts the child to go to the kitchen. If the child doesn't follow within 30 seconds, the session is postponed. The operator sits next to the child and interacts with the food, without encouraging the child to eat. Progress when the child stays seated for 30 seconds without problem behavior for 3 sessions.~Step 3:Shaping Two plates are prepared, and the operator comments on the food. A visible container with the child's favorite food is used for reinforcement. Target behaviors are reinforced with praise and the favorite food. Adjust behaviors if there's no response for 15 seconds or negative emotions occur
Study NCT06656091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simmitinib
Description: simmitinib 6mg,QD ,3 weeks on 1 week off
Study NCT06656091 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: investigator's choice of chemotherapy,include docetaxel or irinotecan.
Description: docetaxel injection 75mg/m\^2,d1,every 3 weeks or ilinotecan injection 180mg/m\^2,d1,every 2 weeks
Study NCT06656546 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Tracheal Ultrasound
Description: In the clinic, one of the routinely used ultrasound machines, either the HM70 EVO Linear Probe (5-12 MHz) or the eSaote MyLab Seven Linear Probe (3-13 MHz), will be selected based on suitability for the procedure at the time. A linear transducer will be placed perpendicular to the trachea at the level of the cricoid membrane. During ETI, visualization of the ETT moving within the trachea, specifically behind the cricothyroid membrane, indicates successful intubation. In contrast, if the ETT is mistakenly placed in the esophagus, a double-lumen appearance lateral to the trachea, created by the ETT within the esophagus, suggests esophageal intubation.
Study NCT06656546 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lung Ultrasound
Description: In the clinic, one of the routinely used ultrasound machines, either the HM70 EVO Linear Probe (5-12 MHz) or the eSaote MyLab Seven Linear Probe (3-13 MHz), will be selected based on suitability for the procedure at the time. Following ETI, the presence of lung sliding will be evaluated using ultrasound with the aid of a linear probe.The transducer will be placed bilaterally along the mid-axillary line, between the second and fifth intercostal spaces, in a coronal orientation. After the ETT is placed and ventilation is initiated, the movement of the visceral and parietal pleura will be assessed. The presence of sliding motion between these pleural layers during ventilation indicates successful intubation, whereas the absence of this movement suggests a failed intubation.
Study NCT06656546 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Diaphragm Ultrasound
Description: In the clinic, one of the routinely used ultrasound machines, either the HM70 EVO Curvilinear Probe (2-8 MHz) or the eSaote MyLab Seven Curvilinear Probe (1-8 MHz), will be selected based on suitability for the procedure at the time. Using a curvilinear transducer, the probe will be placed along the mid-axillary line, approximately at the seventh to ninth intercostal spaces, in a coronal orientation. The movement of the diaphragm during ventilation will be assessed over the spleen and liver. Diaphragmatic motion during ventilation indicates successful ETI, while the absence of bilateral diaphragmatic movement suggests esophageal intubation. If diaphragmatic movement is only observed on one side, it is indicative of endobronchial intubation.
Study NCT06657209 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Insulin resistance testing
Description: Steady state Plasma Glucose test
Study NCT06657209 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Insulin resistance testing
Description: Steady state Plasma Glucose test
Study NCT06657209 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: OGTT
Description: Will collect 5 blood draws during the test to measure insulin secretion